Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate-Reference-Cited by-同舟云学术

Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate

Published:2021-09-02 Issue:15 Volume:35 Page:2481-2487
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Yager Jenna L.,Brooks Kristina M.,Castillo-Mancilla Jose R.,Nemkov Cricket,Morrow Mary,Peterson Skyler,Ibrahim Mustafa,Bushman Lane,Kiser Jennifer J.,MaWhinney Samantha,Anderson Peter L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference26 articles.

1. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics;Kearney;Clin Pharmacokinet,2004

2. Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate;Brooks;J Antimicrob Chemother,2019

3. A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide;Wassner;J Int Assoc Provid AIDS Care,2020

4. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?;Havens;Antimicrob Agents Chemother,2013

5. Effects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind, placebo-controlled trial;Mulligan;Clin Infect Dis,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection;Antimicrobial Agents and Chemotherapy;2024-09-04

2. Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review;Current HIV/AIDS Reports;2024-08-09

3. Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study;International Journal of Antimicrobial Agents;2024-08

4. Modelling the impact of initiation delay, duration and prior PrEP usage on the prophylactic efficacy of FTC/TDF-containing post-exposure prophylaxis;2024-07-22

5. B/F/TAF forgiveness to non-adherence;Sexually Transmitted Infections;2024-07-04